NeuroXess

Shanghai, China · Founded 2021 · Privately Held (backing)

Manufacturer of a brain-computer interface technology intended to advance neurological research and medical applications. NeuroXess is based in Shanghai, China and was founded in 2021. Its last reported valuation was $48.4 million in Dec 2021. It has raised $15.2 million.

Last reported valuation
$48.4M
Oct 2026
Priced at
—
Total raised
$15.2M
Last round
—

Who backs NeuroXess?

9 investors
InvestorType
HSG (Hong Kong)Other
Yonghua CapitalOther
New Alliance CapitalGrowth equity
Chengdu Bio-Town InvestmentOther
Sailing CapitalVenture capital
Lightsilver Capital—
Shanda (Private Equity)—
Shanghai Zhongping Guoyu Asset Management—
Triwise Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NeuroXess investors

9 investors are on record for NeuroXess, including HSG (Hong Kong), Yonghua Capital, New Alliance Capital and Chengdu Bio-Town Investment.

Free account
More of NeuroXess with a free account
  • ·Watch NeuroXess: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like NeuroXess. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View